Estrogens Levels and Receptors Status and Skin Tears
NCT04513405 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200
Last updated 2020-08-14
Summary
Background: Skin tears (ST) or "laceration injuries" or "flap wounds" are injuries that are often found in residents of residential care facilities (RCFs). STs were first defined by Payne and Martin in 1993 as traumatic wounds, located mainly in the upper limbs, caused by "shearing, friction or mechanisms combined with the consequent separation of layers of skin. Skin Tears can cause psychological problems for the patient and represent an economic problem with important repercussions on both the patient and the community. The etiology suggests that the physiological changes of the skin related to old age, together with comorbidity, are among the main risk factors for their onset.
The precise data on the phenomenon are not many, but it is estimated that STs are much more frequent than the same pressure ulcers, observing prevalence rates in RCFs around 40% Therefore, there are several risk factors hypothesized so far. Much evidence has correlated, in various physiological or pathological conditions, the role of estrogens with the functions and aging of the skin.
Objectives: The project will develop on the analysis of populations of residents from RCFs belonging to the national territory. Two populations of residents cared in the RCF will be recruited. A group of subjects suffering from skin tears (group A) and a control group of subjects without skin tears (group B). The inclusion of patients in both groups will take place through a simple randomization procedure. Group A patients will be staged according to the STAR classification for skin tears. For each group a peripheral venous blood sample will be taken (to measure the levels of estrone and estradiol) and a skin biopsy will be performed in order to measure estrogen receptors (ERs) expression. A data collection sheet with angraphic and anamnestic data will be developed to correlate the demographic and comorbidity data with the clinical conditions of the patients and with the laboratory findings from the sampling.
Expected results: The primary endpoint will be the correlation between serum estrogen levels, receptor expression and the presence of skin tears. The secondary endopoint will be Correlation between receptor structure and clinical staging of skin tears.
Future prospectives: We believe that our study may open new frontiers in the prevention and in the management of these skin lesions.
Conditions
- Skin Tear
- Estrogen Deficiency
Interventions
- DIAGNOSTIC_TEST
-
Blood sampling
a peripheral venous blood sample will be analyzed to measure the levels of estrone and estradiol. The sample of the blood sample will be deposited in the red cap tube with a polymeric gel.
- PROCEDURE
-
Shave Biopsy
in the tissues, of the related estrogenic receptors, estrogen α receptors, estrogen β receptors (ER- α, ER-β) and G protein-coupled estrogen receptor 1 (GPER) correlates with the functional status of these receptors
Sponsors & Collaborators
-
University of Roma La Sapienza
collaborator OTHER -
University of Catanzaro
lead OTHER
Principal Investigators
-
Raffaele Serra, M.D., Ph.D. · University Magna Graecia of Catanzaro
-
Nicola Ielapi, R.N. · University La Sapienza of Rome
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2021-09-01
- Completion
- 2022-09-01
Countries
- Italy
Study Locations
More Related Trials
-
The Anabolic Effects of Estrogen on Skeletal Muscles
NCT03020953 ·Status: COMPLETED ·Phase: NA
-
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
NCT02253173 ·Status: COMPLETED ·Phase: PHASE3
-
Transdermal Estrogen in Women With Anorexia Nervosa
NCT03875378 ·Status: RECRUITING ·Phase: PHASE2
-
Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function
NCT03493126 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
NCT02224313 ·Status: COMPLETED ·Phase: PHASE3
-
Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women
NCT00560924 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Estrogen Exposure and Atherosclerosis in Postmenopausal Women
NCT02951949 ·Status: COMPLETED
-
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
NCT04551144 ·Status: TERMINATED
-
Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery
NCT01482416 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
NCT01486979 ·Status: COMPLETED ·Phase: PHASE1
-
Estrogen Receptor Gene Mutations
NCT00342498 ·Status: COMPLETED
-
Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.
NCT04574999 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients
NCT03032848 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women
NCT00224094 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy
NCT02967510 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections
NCT06353269 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The REgistry of Very Early Estrogen and AnovuLation
NCT06583408 ·Status: RECRUITING
-
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
NCT07160504 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Local Estriol Treatment Before Vaginal Repair Surgery
NCT06391372 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate Estradiol Vaginal Tablets vs Promestriene Vaginal Cream
NCT03385551 ·Status: COMPLETED
-
Mechanisms of Skin Repair by Topical Estrogen
NCT00113100 ·Status: COMPLETED ·Phase: NA
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
NCT02449902 ·Status: COMPLETED ·Phase: PHASE2
-
Estradiol Levels in Patients Treated With Estring
NCT01923298 ·Status: COMPLETED ·Phase: PHASE2